Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Why GLP-1 Therapy Alone May Be More Effective Long-Term Clinical trials show that semaglutide alone produces weight loss of 1022% of baseline body weight over 68 weeks, with sustained benefits lasting years when the medication is continued
There are clients that reach their weight loss goals and still choose to continue their treatments after theyve hit their target weight, opting for fewer doses to help keep them on track and feeling their best
Find more information Speak to a medical representative If you are a healthcare provider from the United States, click below to request information directly from the Novo Nordisk Medical Information department
Phase 2 clinical trial data suggests retatrutide may produce greater weight loss (24.2 percent in 48 weeks) compared to semaglutide (14.9 percent in 68 weeks)
While higher-income individuals may manage to afford GLP-1s OOP, lower-income individuals who are more likely to be affected by obesity will face significant access barriers
US$ 23.02
US$ 29.75
US$ 21.69
US$ 28.83
US$ 21.78
